glp-1 gip therapies muscle preservation combination 2025 Optimizing for obesity and diabetes management Current Status of Glucagon-like Peptide-1

A sponsored post is 100% accessible to all subscriber levels and gets your brand, product, or service in front of my audience of BioPharma Industry decision-makers right at the beginning of my next post

Lifestyle measures include maintaining gradual, steady weight loss (0.5-1kg per week is ideal) rather than rapid reduction, which may increase stone risk

In clinical trials for type 2 diabetes, Mounjaro produced weight loss of 9.5% to 12.5%

Not every flat week on the scale means something has gone wrong

Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al

(2003) Treatment of Wilson disease with ammonium tetrathiomolybdate III: Initial therapy in a total of 55 neurologically affected patients and follow up with zinc therapy